What is the level of liabilities of IsoRay this year?
IsoRay has a debt balance of 3.16 M USD this year.
IsoRay Liabilities 2024
IsoRay Liabilities
3.16 M USD
Ticker
ISR
ISIN
US46489V1044
WKN
A0MQNM
In 2024, IsoRay's total liabilities amounted to 3.16 M USD, a 5.05% difference from the 3.01 M USD total liabilities in the previous year.
IsoRay Aktienanalyse
What does IsoRay do?
The company IsoRay Inc is a leading global company in the field of brachytherapy and specializes in the development of novel medical devices for the treatment of cancer. The company's history dates back to the 1980s when it was founded by a team of doctors and scientists. IsoRay Inc's business model is based on the research, development, and manufacturing of medical products used in the treatment of cancer. Brachytherapy is a particularly important focus. This involves a treatment method where radioactive seeds or sources are directly implanted into the tumor. The radiation destroys the cancer cells without damaging the surrounding tissue. IsoRay Inc's product range includes a variety of medical devices and accessories for conducting brachytherapy procedures. The company specializes in the development of high-tech products that enable precise and effective radiation therapy. This includes, for example, radioactive seeds that are directly implanted into the tumor or apparatuses that can selectively use radiation in specific structures of the body. A special focus of IsoRay Inc is computer-assisted planning of brachytherapy treatments. The tumor is precisely measured and the radiation sources are individually customized based on the data to achieve an optimal radiation dose. This planning is done using modern software and is an important factor for the successful treatment of cancer. In addition to research and development of medical products, IsoRay Inc also encompasses the production and distribution of these products. The company operates in more than 30 countries worldwide and collaborates closely with numerous clinics and practices to research and improve new technologies in the field of radiation therapy. One of IsoRay Inc's most well-known products is the "Cesium-131 Brachytherapy seed." This radioactive seed is particularly small and therefore ideal for targeted radiation therapy of tumors. It is used in almost all clinical areas worldwide and is considered particularly safe and effective. Other products of the company include the "Gladius™ Applicator Needle," a device for precise placement of radiation sources in tumors, as well as "Intraoperative Application Systems" that enable effective radiation therapy during surgery. Overall, IsoRay Inc is considered an innovative and successful company in the field of brachytherapy and radiation therapy. The constant development and improvement of its own products is a key factor for the company's success. High quality and close collaboration with research and practice are central to its operations. IsoRay ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing IsoRay's Liabilities
IsoRay's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating IsoRay's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing IsoRay's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
IsoRay's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in IsoRay’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about IsoRay stock
What were the liabilities of IsoRay compared to the previous year?
The liabilities of IsoRay have increased by 5.05% increased compared to the previous year.
What are the consequences of high debt for investors of IsoRay?
High liabilities can pose a risk for investors of IsoRay, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in IsoRay?
Low liabilities mean that IsoRay has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of IsoRay affect the company?
An increase in liabilities of IsoRay can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of IsoRay affect the company?
A decrease in the liabilities of IsoRay can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of IsoRay?
Some factors that can influence the liabilities of IsoRay include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of IsoRay so important for investors?
The liabilities of IsoRay are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can IsoRay take to modify the liabilities?
To change its liabilities, IsoRay can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does IsoRay pay?
Over the past 12 months, IsoRay paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IsoRay is expected to pay a dividend of 0 USD.
What is the dividend yield of IsoRay?
The current dividend yield of IsoRay is .
When does IsoRay pay dividends?
IsoRay pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IsoRay?
IsoRay paid dividends every year for the past 0 years.
What is the dividend of IsoRay?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IsoRay located?
IsoRay is assigned to the 'Health' sector.
Wann musste ich die Aktien von IsoRay kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IsoRay from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.
When did IsoRay pay the last dividend?
The last dividend was paid out on 9/26/2024.
What was the dividend of IsoRay in the year 2023?
In the year 2023, IsoRay distributed 0 USD as dividends.
In which currency does IsoRay pay out the dividend?
The dividends of IsoRay are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von IsoRay
Our stock analysis for IsoRay Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IsoRay Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
